ClearPoint Neuro Announces FDA Clearance of the SmartFrame Array

Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room ClearPoint SmartFrame Array™ Version 1.1 ClearPoint SmartFrame Array™ Version 1.1 SOLANA BEACH, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has received FDA clearance for version 1.1 of its next generation SmartFrame Array Neuro Navi
Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room ClearPoint SmartFrame Array™ Version 1.1 ClearPoint SmartFrame Array™ Version 1.1 SOLANA BEACH, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has received FDA clearance for version 1.1 of its next generation SmartFrame Array Neuro Navi
Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room ClearPoint SmartFrame Array™ Version 1.1 ClearPoint

Katelyn McCray on LinkedIn: Richard Bowman and His Journey with

ClearPoint Neuro (NasdaqCM:CLPT) Stock Forecast & Analyst Predictions - Simply Wall St

Stock Market News 2022-04-28

ClearPoint Neuro Announces FDA Clearance for ClearPoint Prism™ Neuro Laser Therapy System :: ClearPoint Neuro, Inc. (CLPT)

Journal of Neurosurgery Publication Demonstrates Distinct

Katelyn McCray posted on LinkedIn

ClearPoint Neuro (CLPT) Balance Sheet & Financial Health Metrics - Simply Wall St

▷ Listado de empresas del sector Manufacturing

Stephanie Newton Korszen on LinkedIn: ClearPoint Neuro Announces FDA Clearance of the SmartFrame Array™ Version…